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Abstract
Prolyl oligopeptidase (POP) is considered as an important pharmaceutical target for the treatment of numerous diseases.
Despite enormous studies on various aspects of POPs structure and function still some of the questions are intriguing like
conformational dynamics of the protein and interplay between ligand entry/egress. Here, we have used molecular modeling
and docking based approaches to unravel questions like differences in ligand binding affinities in three POP species
(porcine, human and A. thaliana). Despite high sequence and structural similarity, they possess different affinities for the
ligands. Interestingly, human POP was found to be more specific, selective and incapable of binding to a few planar ligands
which showed extrapolation of porcine POP in human context is more complicated. Possible routes for substrate entry and
product egress were also investigated by detailed analyses of molecular dynamics (MD) simulations for the three proteins.
Trajectory analysis of bound and unbound forms of three species showed differences in conformational dynamics, especially
variations in b-propeller pore size, which was found to be hidden by five lysine residues present on blades one and seven.
During simulation, b-propeller pore size was increased by ,2A ˚ in porcine ligand-bound form which might act as a passage
for smaller product movement as free energy barrier was reduced, while there were no significant changes in human and A.
thaliana POPs. We also suggest that these differences in pore size could lead to fundamental differences in mode of product
egress among three species. This analysis also showed some functionally important residues which can be used further for
in vitro mutagenesis and inhibitor design. This study can help us in better understanding of the etiology of POPs in several
neurodegenerative diseases.
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Introduction
Serine proteases are the examples where relationship between
homology and substrate specificity is still a paradox. Despite high
sequence identity in any two proteases, they can be quite specific
towards a given macromolecular substrate [1]. Unlike other
traditional serine proteases like trypsin and subtilisins, POP cleaves
peptides which are smaller than 30 amino acids in length [2–4].
Binding of small peptides to POP is essential for many
physiological processes and has gained insights as a target for
the treatment of numerous disorders like depression, amnesia,
schizophrenia, trypanosomiasis, bipolar affective disorder etc [5–
7]. A recent study also showed lower plasma POP activity in
patients of multiple sclerosis [8]. This peptidase has been
implicated in neurodegeneration, as well as in the modulation of
the inflammatory response [8]. In spite of enormous studies of role
of POP in various diseases the precise biological function of
protein is still unknown.
POP is a widely distributed enzyme and has been cloned and
isolated from several sources [9–15]. The X-ray crystal structure of
enzyme shows unique domain architecture with a catalytic a/b
hydrolase domain and an unusual b-propeller domain. Propeller
domain is based on radially arranged seven-fold repeat of four-
stranded antiparallel b sheets. In the case of POPs, this domain is
considered to be of the ‘‘open-velcro’’ topology, where first and
seventh blades are connected only through hydrophobic interac-
tions. The catalytic triad (Ser 554, His 680, and Asp 641) is hidden
and located at the interface of two domains. This unique propeller
which is absent in other a/b hydrolases, acts as a lid to hide the
active site and also as a selectivity or gating filter, thereby allowing
only small peptides to reach active site [16]; despite central inter-
domain cavity, that can accommodate bigger ligands. Various
experimental studies have suggested concerted movement of
propeller and peptidase domains are necessary for enzyme activity
[17].
Evolutionary studies of POP family shows that plant POP
diverge before mammalian POP [18]. Phylogenetic analysis
showed that POP is the most conserved enzyme in POP family
[18]. In animals, POP is widely distributed with high concentra-
tion found in the brain, and its involvement in the control of
several mammalian peptide hormones signaling pathways have
been studied extensively [19–20]. As abnormal POP activity is
found to be linked with various neurological disorders, for
preclinical trials porcine POP is widely studied as model to
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reported inhibitors entered clinical trials [27], but their use as drug
has not been reported yet. Unlike other members of POP family
crystal structure of the POP does not explain the possible passage
for substrate/product entry/egress therefore substantial confor-
mational changes are expected. Despite the enormous amount of
data from both experimental and computational studies, mecha-
nisms of substrate/inhibitor entry and product egress are still
unknown [28,29]. Recent crystal structure of bacterial POP (S.
capsulata) in open form suggests large opening between two
domains for substrate/inhibitor entry, while presence of inhibitor
shuts the opening [30]. Comparative analysis of the two structures
highlights role of inter-domain dynamics. However, from other
crystal structures of closed form of mammalian POPs, porcine
POP for instance, have various hydrogen bonds that act like a
bridge in connecting two domains along with numerous loops
from b-propeller domain which behaves like a covering sheath.
Sequence analysis of these two POPs suggests salt bridges, present
in bacterial POPs that function as a latch for inter-domain opening
movement, is not conserved in porcine [27]. This highlights the
fact that bacterial POP may not represent a common and unified
mechanism for action of every POP enzyme of other species. So, it
is also anticipated that different POP species can have different
substrate entry or product egress mechanisms [27]. Previous
studies have shown that plant POPs are distant members of same
family but till now their function in plants is not known.
Unavailability of drugs and no successful clinical trials on human
has inspired us to carry out this analysis to better understand the
differences of POP among different species if any.
In the present study, we have carried out in-depth analysis and
comparison of POPs from three different species human, porcine
and plant (A. thaliana) in terms of ligand specificity and binding.
This comparison was done to better understand the differences
and conformational dynamics of the protein. We have focused on
two main issues firstly, to what extant extrapolation of porcine
POP to human POP is correct and secondly investigating the
possible passage for substrate/product entry/egress. To unravel
the above mentioned questions we have applied computational
based approaches like molecular docking and dynamics. We were
interested in studying plant POPs as they are distant members of
same family so it would be interesting to see from evolutionary
perspectives like how a distant member of same family behaves as
compared to newly diverged members. Moreover, few naturally
occurring plant molecules are reported as POP inhibitors having
therapeutic applications but nothing much is known about their
function and presence in plant system [21–25]. Three possibilities
of substrate entry were considered: (1) Movement of side chains
present at b-propeller pore will allow annulus of tunnel to become
broad (2) the first and seventh blade will move apart, thereby
increasing pore size (3) Hinge-like motion between two domains
causing separation, thereby substrate entry [31]. Further compar-
ison of all the reported cavities (Figure 1) present in protein, that
includes b-propeller, inter-domain (between two domains reported
by Polgar and coworkers, [28]) and a recently reported cavity (by
Tarrago and coworkers found using cryo-electron microscopy
which is present just above active site [32]) was carried out for
unrevealing the possible entry/exit mechanism.
Exhaustive examination and analysis of these POP species
showed differences in binding affinities of different inhibitors
which include differences in binding in porcine and human POPs.
Interestingly, human POP was found to be more selective and
specific and also showed hindrance in binding to some ligands
which binds well to porcine and A. thaliana, this indicates the
extrapolation of porcine to human POP will be difficult in all
cases. Detailed analyses of molecular dynamics trajectories of
bound/unbound form reveals the dynamic conformational
changes associated with the ligand binding in three POP species.
Striking differences in b-propeller pore size in bound forms of
three POP species were noticed. We have also shown that smaller
product movement is possible from b-propeller in porcine, while it
may differ in other two species.
Methods
Alignment and model preparation
Protein sequence of A. thaliana POP was retrieved from TIGR
(The Institute of Genomic Research) database [33]. The sequence
obtained was subjected to BLAST (Basic Local Alignment Tool)
against PDB (Protein Data Bank) to extract information about
suitable structural template and to PSIPRED (Protein Structure
Prediction Server) for predicting secondary structural elements,
respectively [34–36]. Sequence alignment was done using
CLUSTALW [37] and Joy4.0 program was used to annotate
the alignment using three dimensional structural information of
template [38]. DSSP (Database of secondary structure assignment)
was employed for the assignment of secondary structure [39].
Crystal structure of porcine POP (PDB ID: 1E5T) was used as a
template for the construction of model. Alignment of query and
template was considered to build the model using MODELLER
(version 9.1, [40]). A set of 100 models were generated, from
which lower energy structure according to DOPE (Discrete
Figure 1. Cavities present in POP. Bottom arrow indicates b-
propeller cavity which continues till active site and form another smaller
cavity near active site shown in red color (Tarrago et al 2009), inter-
domain cavity is shown in green color.
doi:10.1371/journal.pone.0026251.g001
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Geometric inaccuracies of the structural model were evaluated by
subjecting the model to PDB-ADIT validation server, which
validates using PROCHECK [41–42]. The structure was further
energy minimized with the SYBYL software package (version 7.1)
using Tripos forcefield [43]. For first 500 steps minimization was
carried out with steepest descent which was followed by 200
iterations of conjugate gradient with distant dependent dielectric
constant equal to 1, non-bonded interaction cutoff value of 8 and
was terminated at the convergence of 0.05 kcal mol A ˚ 21. The
final structure was validated again using the PROCHECK and
PROSA that checks for high energy regions of the modeled
structure [44]. Structural model was structurally aligned with the
experimental structure and rendered using PyMOL.
Ligand selection
The set of ligand molecules studied in this work include known
inhibitor Z pro prolinal (ZPR) and related molecules like Z-prolyl
pyrrolidine, Z-prolyl prolinol, Z-prolyl azetidine, Z-phenyl alanine
azetidine, pyrazinone [19,45]. Besides this, naturally occurring
plant flavonoid inhibitors baicalein [24] and berberine [25] were
also used which are known porcine POP inhibitors. These ligands
were either downloaded from PubChem or were constructed using
CHEMDRAW software. Few other ligands like Y-29794 [46–48],
UAMC [49], ono-1603 [50–51], S-17092 [52–56], SUAM-1221
[57–61], and JTP4819 [62–67] were also considered for this study.
Coordinates were saved and subjected to CORINA for two
dimensional to three dimensional conversions. The three dimen-
sional structure of porcine POP (1QFS), which is ligand bound
form with Z pro prolinal was downloaded from PDB. This
structure was determined using X ray crystallography with
resolution of 2 A ˚. The energy of ligand molecules were minimized
for 200 runs using steepest descent followed by 100 runs of
conjugate gradient using SYBYL software. Each of the minimi-
zation methods were carried out with Tripos forcefield.
Docking studies
In order to carry out the docking simulation, AutoDock 4.0 [68]
was used. It is one of the most suitable methods for performing
molecular docking of ligand to their macromolecular receptors.
Here rigid docking protocol was considered, where both ligands
and receptors were kept rigid. The Graphical User Interface
program ‘‘Autodock tools’’ was used to prepare, run and analyze
the docking simulations. Polar hydrogen’s were added into the
receptor PDB file for the preparation of protein in docking
simulation. Gasteiger charge was assigned and non-polar hydro-
gens were merged to the ligands. Autodock requires grid maps,
and grid must surround the region of interest in the macromol-
ecule. In this study one of the catalytic triad residues Ser 554 was
selected as the active site residue. So, the grid was centered on this
catalytic active region of the receptor. The grid box size was set at
60, 60 and 60 A ˚ (x, y and z). For blind docking grid size was
increased so that entire protein can be accommodated inside grid
where grid dimensions were 68, 62 and 82 A ˚ (x, y and z).
AutoGrid program was used to produce grid maps. The spacing
between grid points was 0.37 A ˚ and 1 A ˚ for active site and blind
docking respectively. The Lamarckian Genetic Algorithm (LGA)
was used to search for the best conformers. During the docking
process, a maximum of 100 conformers were considered for each
compound. The population size was set to 150 and the individuals
were initialized randomly. Maximum number of energy evaluation
was set to 2.5610
26, maximum number of generations to 27000,
maximum number of top individual that automatically survived to
1, with a mutation rate of 0.02 and a crossover rate of 0.80.
Electrostatic charge distribution
The Adaptive Poisson-Boltzmann Solver (APBS) program was
employed to calculate the electrostatic charge distribution of
porcine and human crystal structure [70]. Electrostatic charge
distribution was also mapped on the theoretical structure of A.
thaliana and comparison was made with respect to possible cavities
present in the protein. PyMOL was used for the visualization of
the surface representation.
Molecular Dynamics Calculations
MD calculations at room temperature were carried out using
Gromacs [71] software with gromos96 force field for porcine
(1QFS), human (3DDU) [72] and the model of A. thaliana POP
(generated in this work). Proteins were immersed in cubic water
box of spce water model with box edges 9 A ˚ from molecule
periphery. 21 sodium ions were added to achieve electroneutrality.
The system was subjected to pre-equilibration process that
involves minimization using steepest descent for 6000 steps
followed by position restrained dynamics for 20 ps. MD
calculations were performed at constant volume and temperature
for both bound and unbound forms each for 20 ns of three POP
species. The system was simulated under periodic boundary
conditions with cutoffs of 10 A ˚ each for electrostatic and Van der
Waals terms. Replicate of the MD runs were also performed using
different seed numbers. Snapshots were collected after every 1 ps.
Prodrug server was used to obtain drug parameters [73]. Strong/
short (distance between nucleophiles ,2.8 A ˚) hydrogen bonds
between two domains were calculated using HBPLUS [69] for the
comparison among species.
Results
Alignment and model preparation
For generating structural model of A. thaliana POP BLAST
search was performed, using plant POP as a query against PDB
database, suggests POP from porcine brain (PDB ID: 1E5T,
resolution 1.7 A ˚) as a potential template for modeling of plant
POP. Plant and porcine POPs are definite homologues with
sequence identity of 53% (Figure 2a). Alignment was analyzed to
check preservation of conserved residues along with catalytic triad
residues present towards C-terminal of the sequence. There was
good agreement between the secondary structural elements of
both sequences. Catalytic triad was also found to be in similar
orientations in theoretical structure as in porcine POP (Figure 2b).
Overall, 95% of residues were present in allowed region
representing a good model quality.
Electrostatic charge distribution
Electrostatic charge distribution was mapped on all three POP
species for finding species specific surface differences. Analysis of
electrostatic charge distribution reveals deviations in surface
electrostatics at different cavities present in POP proteins of three
species (Figure 3). Comparison was done with respect to known
cavities present in porcine protein of known structure to study
differences in possible initial binding sites of ligand. In order to
check whether there are species-specific differences, we have
compared electrostatic distribution on the surfaces of human and
A. thaliana POP with porcine POP. Intensity of positive potential
was found to be varying in the three protein structures. Striking
differences were observed among three species: mouth of the b-
propeller cavity was found to have more positive potential in
human POP as compared to porcine, while A. thaliana POP shows
even higher positive potential than other two because of the
presence of an extra Arg402 (Figure 3a, Figure S1). These
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and seventh blades of b-propeller. Blade 1 of both porcine and
human POP was having high positive surface potential. Further,
the comparison of cavity present just above the active site by
Tarrago and coworkers [32] suggests that surrounding residues
have higher positive potential in humans, as compared to porcine,
while it was found to be near-neutral in A. thaliana (Figure 3b).
These differences in the protein electrostatics may lead to
difference in the recognition and initial binding of the ligands in
three species.
Molecular Docking
Most of the POP inhibitors contain a proline skeleton (exactly a
proline group or proline analogs). The first effective inhibitor
which was discovered was Z-pro prolinal. The set of ligand
molecules studied in this work include Z-pro prolinal, its related
compounds and various other molecules which were tested for
preclinical trials (Y-29794, UAMC, ono-1603, S-17092, SUAM-
1221, and JTP4819) in other organisms like rat, porcine etc.
Molecular docking simulations were conducted using AutoDock4.
For all the docking runs, minimum energy conformation was
selected.
Inhibitor docking
In order to identify residues potentially involved in ligand
binding and to analyze its functional importance, the receptor was
docked to different ligands. Initially, rigid docking approach was
used. Each docking pose was analyzed and compared in three
species. Ligands were found to be docked in different conforma-
tions and with varying affinities, as reflected by docking scores
(Figure 4). Interestingly, few of the ligands Y-29794, UAMC, ono-
1603, S-17092, thioxo and Z-pro prolinol showed some hindranc-
es in binding to human POP as revealed by their positive binding
energies (Figure 4a).
For ligands that showed no evidence of binding (positive
energies) using rigid docking approach, docking runs were
repeated after subjecting the ligands to flexible docking, where
flexibility was induced in ligands alone. This was done in order to
provide more optimal interactions between protein and ligand
during the docking. Ligands were again found to bind with
different affinities in three POPs. Some of the ligands that were
showing poor scores in rigid docking were found to bind well when
the ligand conformation was permitted to be flexible. However,
still two planar ligands Y-29794, UAMC were incapable of
binding. This binding incapability suggests difference in selectiv-
Figure 2. Model generation. a) alignment between query (At1g20380) and template (PDB ID: 1E5T, porcine) generated by CLUSTALW, sequence
identity was found to be 53%. a/b hydrolase domain is cyan colored and b-propeller is shown in yellow color. Active site residue conservation is
shown in red color b) homology model of A. thaliana POP generated using porcine POP as a template. Catalytic triad is shown in magenta color.
doi:10.1371/journal.pone.0026251.g002
Figure 3. Electrostatic charge distribution of POP of three species. a) down the b-propeller pore view of electrostatic potential. Three species
showed differences in electrostatics. A. thaliana POP showed more positive potential; similarly differences were also present in human and porcine
POP proteins b) Electrostatic potential of inter-domain cavity and recently reported cavity (Tarrango et al 2009). In A. thaliana later cavity was hidden.
doi:10.1371/journal.pone.0026251.g003
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binding orientation was found to be different than porcine and A.
thaliana POP. In Y-29794, change in orientation of binding leads to
interaction with more polar residues like Thr481, Ser479,
Tyr471and Asn483 which causes hindrance in binding while in
porcine smaller residues like Ala and Gly are present. Similarly,
UAMC binds in different orientation causing short contact in
human POP. Plant based naturally occurring animal POP
inhibitors baicalein and berberine were found to bind with high
affinities to A. thaliana POP protein too, which shows they are
effective ligands but their function in plants is still not known.
Other ligands were also found to bind well to A. thaliana POP, but
whether their function (inhibitor) is similar in plants is still an area
to be explored.
In order to identify possible regions of protein where ligand (Z-
pro-prolinal) can bind effectively, blind docking approach was
used. Grid was increased to dimensions which can accommodate
entire protein inside and then comparisons among three POPs
were carried out. In porcine POP, by following the various
docking poses, it appears that the ligand can make specific path
right from mouth of b-propeller to active site of protein, while it
was not very well distributed and found to be present at specific
places like end of a/b hydrolase domain and in middle of b-
propeller cavity in human (Figure S2). In order to validate whether
binding is not random, dummy molecule sucrose was also docked
to porcine POP (Figure S3) as a negative control. Sucrose was
found to bind all over protein (unspecific binding) while ligand
ZPR had more specific binding. In human POP, ligand binding
was restricted to some particular regions only, though CASTp [74]
results showed b-propeller cavity is more voluminous in human
(11323 A ˚ 3) as compared to porcine (10471 A ˚ 3). Besides this,
binding of Z-pro-prolinal was more feasible in human (binding
energy 210.1 to 3.1 kcal/mol), as compared to porcine (binding
energy 27.1 to 24.3 kcal/mol) and A. thaliana (binding energy
25.2 to 23.3 kcal/mol) POPs.
Substrate/Product docking
All short peptides with an internal proline residue are potential
POP substrate. Blind docking of POP with substrate angiotensin
IV (V-Y-I-H-P-F) was also carried out to known possible regions of
binding [75]. This was found to be similar (data not shown) as
when inhibitor Z-pro-prolinal was docked. Binding was restricted
to some particular regions in human, unlike porcine POP, but
binding feasibility was higher (energy/residue 23.3 kcal/mol in
human, 21.9 kcal/mol in porcine). Similarly, N terminal (V-Y-I-
H-P) and C terminal (F) products were docked to human and
porcine POP. C-terminal product was docked successively after
docking N-terminal product. Comparison of percentage docked
poses of substrate and product showed some differences with
respect to known cavities and domains (Figure S4). It was found
that substrate has tendency to bind at particular regions like b-
propeller cavity, functionally important loop (residues 192–205)
and towards a/b hydrolase domain of protein while products were
present at multiple sites which were reported till now including
inter-domain cavities reported by Polgar and coworkers [28] and
Tarrago and coworkers [32], reflecting its multiple egress sites.
Molecular dynamics
Overall, nine simulations were run, with a total duration of
,0.21 ms. However, rather than running a single long simulation,
we explored the effect of presence/absence of ligand (ZPR, each
20 ns). The rationale behind these multiple simulations was to
understand differences in dynamics of POP protein in three
species, also in the ligand unbound and bound conformations.
Briefly simulations performed with replicates were:
1. Six simulations each 20 ns of bound/unbound form of human,
porcine and A. thaliana.
2. One simulation (20 ns) for unbound form of human when
lysines were mutated.
3. One 45 ns simulation where ligand was at mouth of b-
propeller pore in porcine POP.
Simulation with bound ZPR/unbound forms. Con-
formational stability was assessed by the drift of the protein from
the crystal structure as measured by root-mean-square deviation
(rmsd) of C
a atoms from their initial coordinates (Table 1). During
simulation, all the three proteins were found to be stable (Figure 5).
Unbound form of A. thaliana showed higher deviations as
compared to porcine and human POP, overall b-propeller
domain showed higher fluctuations than a/b hydrolase domain
(Figure S5). In the ligand-bound form, rmsd of the drug position
Figure 4. Rigid and flexible docking binding scores. a) Rigid docking scores of human, porcine and A. thaliana POP. Some of the ligands
showed hindrance in binding to human POP as revealed by their positive energy scores. Different ligands showed difference in binding affinities to
three species of POP. b) Flexible docking scores of human, porcine and A. thaliana POP. After inducing flexibility in ligands still two of the ligands
were incapable of binding to human POP.
doi:10.1371/journal.pone.0026251.g004
Table 1. Root mean square deviations (rmsd) of simulations carried out. rmsd of replicate run is shown in brackets.
Simulation Duration[ns] Form C
a ´ rmsd A ˚[D1 +D2] *D1 [b-propeller] [A ˚] *D2 [a/b hydrolase] [A ˚]
Porcine 20 Bound 1.77 (1.64) 1.80 (1.49) 1.59 (1.31)
20 Unbound 2.02 (1.63) 2.04 (1.53) 1.42 (1.13)
A. thaliana 20 Bound 2.06 (1.74) 2.00 (1.72) 1.79 (1.44)
20 Unbound 2.20 (2.13) 1.77 (1.69) 2.15 (1.94)
Human 20 Bound 2.02 (1.96) 1.89 (1.83) 1.82 (1.25)
20 Unbound 1.64 (1.95) 1.63 (1.97) 1.51 (1.55)
Porcine 45 Drug at b propeller 1.45 (1.72) 1.40 (1.66) 1.32 (1.63)
*Deviations of two domains were also calculated separately.
doi:10.1371/journal.pone.0026251.t001
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porcine POP hence more mobility of drug as compared to human
and A. thaliana (Figure S6). Rg plots showed a slight decrease
(,0.3 A ˚) in bound forms of POPs. Flexibility of residues was seen
by measuring rmsd during simulation. Like other studies done
before (Polgar and coworkers [28] and Tarrago and coworkers
[32]), we also found that loops present at inter-domain region
showed high fluctuations; besides, residues 266–275 of b-propeller
blade 4 also showed very high fluctuation, along with other loops
connecting b-strands of blade 1, 2, 5 and 7. This, together with the
higher positive potential at the propeller mouth of A. thaliana POP,
might suggest that the substrate entry is more likely by inter-
domain movements.
Conformational changes during simulation. Comparison
among three POP species was done with respect to known cavities
present in structure to understand the possible passage of substrate
entry and product egress. Bound form simulations revealed
opening and closing of present cavities of proteins in three POP
species. In porcine and human bound form POP during initial
4 ns of simulation, inter-domain cavity (Polgar and coworkers
[28]) was present, but after that it was hidden continuously till the
end of simulation. Similarly, cavity present in continuation with b-
propeller (Tarrago and coworkers [54]) also followed the same
trend. On the other hand, in unbound forms, above mentioned
cavities were hidden revealing incapability of these cavities in
absorbing a substrate and hence its accessibility to active site.
Interestingly, we found that b-propeller pore size showed
variations in diameter. During simulation, some species-specific
striking differences in pore size of b-propeller in three POPs,
especially in bound form were noticed. We discovered that in
porcine there was continuous increase in pore diameter size from
,5.5 A ˚ to ,7.3 A ˚ during simulation while in human (,4.5 A ˚ to
,5.0 A ˚) and A. thaliana (,3.0 A ˚ to 4.2 A ˚) POP there were not
high changes in pore size (Figure 6, Figure 7 and Figure S7).
Overall, during simulation b-propeller pore size was increased for
porcine, while for human POP it does not show any substantial
changes. On the other hand, pore size was decreased continuously
for A. thaliana POP which shows possibility of some alternate role
of b-propeller in plant systems. Pore sizes in unbound forms of
POP of human and porcine were smaller in diameter than
respective bound forms. Inter-domain distance (Pro34-Thr200) in
porcine and human unbound form was increased by 2 A ˚ and 3 A ˚
respectively while A. thaliana was also amenable to such changes.
This shows domain opening motion while such high differences
were not present in bound forms (Table S1). During simulation
distance between blade 1 and 7 (Cys78-Glu397) was decreased in
both bound/unbound forms of porcine and human suggesting the
incapability of movement of blades of propeller (Table S2).
As both domains are found to be connected via series of
hydrogen bonds, we checked how hydrogen bonding interactions
are changing during simulation including replicate runs. In
unbound form, both porcine and A. thaliana showed similar trend
of loosening of interactions between two domains as number of
strong hydrogen bonds were found to be reduced (Table S3) in
Figure 5. Root mean square deviations (rmsd) of backbone Ca of three POP species during simulation. a) rmsd of bound form of
porcine (black), human (red) and A. thaliana (green) POPs b) rmsd of unbound form of porcine, human and A. thaliana POPs. Dotted line indicates
rmsd of replicate runs.
doi:10.1371/journal.pone.0026251.g005
Figure 6. Deviations in b-propeller pore size. During simulation of bound form of porcine, human and A. thaliana POP. In porcine diameter of
pore was found to be increasing in while human and A. thaliana it was found to be decreasing (Figure S7 for replicate runs).
doi:10.1371/journal.pone.0026251.g006
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th ns structure, while in human unbound form, more strong
bonds were formed which showed its dissimilar trend as compared
to porcine and A. thaliana. All bound forms were found to be more
intact during simulation as shown by increase in number of strong
hydrogen bonds during simulation which showed that, in substrate
bound condition release of product from opening of two domains
is very unlikely. We also noticed changes in strong hydrogen bonds
between blade one and seven in the unbound form. Bound form of
porcine was more relaxed having less number of strong hydrogen
bonds after 20 ns than human and A. thaliana POPs.
Interplay of lysines present on blade one and
seven. During simulation studies of POP we discovered that
b-propeller pore was hidden by side chains of lysine residues, three
of which are present on blade1 (Lys81, Lys82, Lys84, porcine
residue numbering) and two on blade7 (Lys389 and Lys390,
porcine residue numbering). Movement of the side chains of these
lysines causes fluctuations in b-propeller pore size. Therefore, the
conservation of these lysine residues was checked across different
species to know if they are present and conserved universally. For
this multiple sequence alignment of POPs from different lower to
Figure 8. Conservation of lysine residues across lower to higher organisms. Lysines were conserved in all mammalian species and also in
amphibian Xenopus. Coloring: Archaebacteria (yellow), mammals (dark grey), amphibian (blue), plants (orange), arthropods (blue, below orange),
nematodes (light yellow), bacteria (light grey). Presence of lysines are shown using red color, while absence using green color.
doi:10.1371/journal.pone.0026251.g008
Figure 7. 20
th ns bound form structure of porcine, human and A. thaliana POPs. b-propeller pore size was found to be biggest in porcine,
while in human and A. thaliana it was small. Drug (ZPR) is shown in magenta color, active site is colored red.
doi:10.1371/journal.pone.0026251.g007
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bians, nematodes and plants) was carried out. Interestingly,
alignment shows differences in conservation of lysine among
different species. From all the species considered for the analysis
lysines were totally conserved in mammals and amphibians as
shown in Figure 8. In human POP, we observed continuous
hindrance in b-propeller pore opening because of side chains of
lysines therefore smaller pore size as compared to porcine. This
observation leads us to mutate all lysines present on mouth of b-
propeller with smaller positively charged histidine. The only
intention to mutate lysine with histidine was not to disturb charge
distribution on the surface of protein. We found that after
mutation pore size was increased to 5.5 A ˚ than wild type (4.5 A ˚).
Further to see dynamics of mutated protein, we subjected the
mutant (unbound) to undergo 20 ns simulation like wild type
protein. Analysis of trajectory of mutated human POP showed
Table 2. Hydrogen bonds at drug binding site (active site) in three POP species.
POP species Crystal structure/0 ns Length of H-bond* After 20 ns Length of H-bond
Porcine
run1 Tyr-473 [OH]–ZPR-711 [O16] 3.08 Trp-595 [NE1]–ZPR-711 [O2] 2.96
Tyr-473 [OH]–ZPR-711 [N14] 3.38
Trp-595 [NE1]–ZPR-711 [O2] 2.96
run2 Tyr-643 [OH]–ZPR-711 [O16] 2.70 Arg-643 [NE]–ZPR-711 [O9] 2.55
Arg-643 [NH1]–ZPR-711 [O9] 2.85 Arg-643 [NH2]–ZPR-711 [O9] 2.65
A. thaliana
run1 Arg-661 [NH1]–ZPR-732 [O9] 2.68 Trp-609 [NE1]–ZPR-732 [O9] 3.32
Arg-661 [NH1]–ZPR-732 [O9] 2.84
run2 Trp-609 [NE1]–ZPR-732 [O9] 2.94 Arg-661 [NH1]–ZPR-732 [O9] 2.77
Arg-661 [NH1]–ZPR-732 [O16] 2.99
Arg-661 [NH1]–ZPR-732 [O9] 2.81
Human
run1 Trp-592 [NE1]–ZPR-710 [O16] 2.16 Trp-592 [NE1]–ZPR-710 [O16] 2.11
Arg-640 [NH1]–ZPR-710 [O9] 3.01
Arg-640 [NH1]–ZPR-710 [O2] 3.07
run2 Trp-592 [NE1]–ZPR-710 [ O16] 3.07 Trp-592 [NE1]–ZPR-710 [O16] 3.01
Arg-640 [NH1]–ZPR-710 [O9] 2.93 Arg-640 [NH1]–ZPR-710 [O9] 3.07
Residues in bold indicates same hydrogen bond interactions found during replicate runs.
*H-bonds were defined using a 3.5 A ˚ cutoff distance [H–acceptor] and a 30u cutoff angle [donor–H–acceptor].
doi:10.1371/journal.pone.0026251.t002
Figure 9. Conformational changes in b-propeller pore size in human POP after in silico mutation of lysine residues. Yellow color
indicates change in pore size.
doi:10.1371/journal.pone.0026251.g009
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showed that other species of POP in which lysines are absent and
are replaced by smaller amino acids like Ile, Val, Ser etc can have
bigger pore size which can lead to differences in substrate entry or
product egress. On the other hand if lysines are replaced by longer
length amino acids like arginine (e.g. A. thaliana) which in turn can
contribute in decreasing or completely hiding the b-propeller pore
opening.
Protein-ligand interactions. Ligand (ZPR)-interacting
residues (present within 5 A ˚ from any one of the ligand atoms)
were examined, during the course of simulation of the ligand-
bound form, to see if changes in interaction with the ligand
happen in comparison to the initial structure. Hydrogen bond
interactions of ligand with the protein were compared with
porcine POP crystal structure. Surprisingly, neither of the species
retained the same binding mode as seen in X-ray structure as after
20 ns orientation of the ligand in three POPs was slightly different
than the initial structure (Figure S8). Residues present within 5 A ˚
of the binding site can be functionally important as they play an
important role in biological activity of the molecule and also take
part in biological interactions hence mapping of these interactions
was carried out. Hydrogen bonding interactions with Tyr473,
Trp595, and Arg641 were observed. Importantly, these interac-
tions between the ligand and interacting residues were not
conserved in three POP species (see Table 2 for details). After
20 ns, numbers of hydrogen bonds were found to decrease in
porcine and human and we also noticed few new interacting
residues coming within 5 A ˚ region of drug. We also noticed
differences in interacting hydrophobic residues among the three
POPs. Some of the residues, like Ile-591 and Phe-476, retain
highly conserved interactions during the 20 ns simulation in both
porcine and A. thaliana POPs, while only Ile590 was conserved in
human POP suggesting that rational mutations of the above
residues could be carried out to study the functional importance of
these residues.
Simulation from docked poses. Results of blind docking
showed the capability of ligand to bind at multiple sites of POP.
So, from blind docking, two docked complexes were selected
(firstly, when ligand was at the mouth of b-propeller, secondly,
when ligand was at the inter-domain cavity), for molecular
dynamics studies to better understand the passage for ligand
entry/egress. A 45 ns simulation of porcine POP docked complex
was performed, where ligand was at the mouth of b-propeller.
Distance plot between centre of mass of drug and nucleophilic
Ser554-OH was plotted to see drift towards active site (Figure 10).
We observed that distance was reduced to more than 1 A ˚ which
depicted potentiality of b-propeller in ingesting a ligand. However,
no such distance reduction could be observed when the ligand was
in one of the other docked pose (like at inter-domain, recently
reported cavity) when 20 ns simulation was carried out. In latter
case, distance was decreased in initial few picoseconds only and
was constant throughout 20 ns run (data not shown). A distance
reduction of .1A ˚ in 45 ns simulations may not be considered
significant enough and longer length simulations could be carried
out in future to understand the theory of ligand ingestion from b-
propeller.
Smaller product movement. Cleavage of any small peptide
like angiotensin-IV by POP produces two N- and C-terminal
products. SLITHER [76] generates contiguous conformations of
ligand across the tunnel. Docking of smaller product in porcine
POP (C-terminal) by SLITHER showed that its egress can be
through b-propeller pore. Different snapshots generated from
molecular dynamics run were used to see movement of C-terminal
product from b-propeller pore opening. Further, comparison of
free energy profiles was done for different snapshots and it was
observed that at 0 ns free energy profile generated showed major
barrier at mouth of b-propeller pore while after 20 ns simulated
structure having bigger pore size, this barrier was reduced which
confirms that smaller product can egress from b-propeller pore
(Figure 11). These changes of energetic profiles upon the
conformational changes provide an explanation why some
conformational changes are beneficial for the entrance or exit of
substrate/product.
Discussion
Differences in structural dynamics among proteins are of key
importance which can influence the entire thermodynamics and in
turn their biological responses. We have applied molecular
docking and dynamics based approaches for exhaustive compar-
ison of prolyl oligopeptidase of three species including porcine,
human and A. thaliana. POP is an important therapeutic target and
is found to be associated with different disorders due to which
hundreds of compounds have been tested for POP inhibitory
activity. Porcine POP is a well-known model system on which
numerous studies have been carried out. Many of POP inhibitors
reached preclinical trial stages but till now drugs are not available
for public use. This raises the question that to what extent
extrapolation of porcine POP to human POP is correct? Plant
POPs are poorly understood distant members of same family
which diverged a bit earlier than human and porcine POPs.
Therefore, this study was carried out to structurally compare
porcine, human and plant POPs in detail at two levels: 1) To
identify how ligand binding affinities differ among them 2) To
compare their structural dynamics which was seen with both
bound and unbound forms to envisage the possible path for
substrate entry/product egress and to investigate differences
among species if any.
Crystal structure and homology model of prolyl oligopeptidase
from different species provides an opportunity to examine the
differences in structural scenario of three POP species. These POP
species were found to have high structural similarities, although
plant POPs are evolved before animal POPs and are distant
members of same family. Even though sequence and structural
similarity among these species are high, their ligand binding
affinities are very different. Further, the level of sequence
similarities between the three POPs that we chose to study
provides a unique opportunity to perform analysis of amino acid
changes but in a structural context. At such high sequence
identities, the homology models derived are of high quality (Sali
and coworkers [77], Figure S10) enough to make gross
comparisons of spatially proximate residues and conformational
changes as evidenced by molecular dynamics. Moreover, by
means of a complete threading of a plant POP on porcine POP
template, we are able to compare the sequence-specific changes
without dependence on the backbone and overall fold of the
protein. We also noticed that some of the ligands were incapable of
binding to human POP which indicates high specificity and
Figure 10. Simulation from blind docking pose where drug was at mouth of b-propeller pore. a) 0
th ns structure (protein: green, drug:
red) and 20
th ns structure (protein: blue, drug: magenta) were superimposed and distance plot of catalytic Ser-554 hydroxyl group and centre of mass
of drug was plotted. Distance was found to decrease by more than 2 A ˚. B) distance plot.
doi:10.1371/journal.pone.0026251.g010
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be more feasible in human POP. Naturally occurring plant based
animal inhibitors like berberine, baicalein were observed to bind
well to plant POP which showed their binding capacity but it is yet
to characterize whether they are plant POP inhibitors or not, and
if yes, how they are localized and regulated in plant system? This is
still a fascinating area to be explored in detail.
Based on the detail structural analysis of POPs, we suggest that
dynamic conformational changes are associated with the ligand
binding in plant and animal POPs. Loosening of interactions
between b-propeller and a/b hydrolase domains indicates plants
and animal POPs also follow similar trend of domain opening
motion for substrate entry as previously observed in bacterial
POPs. However, our bound form simulations depicted the
intactness of two domains revealing the release of product from
some alternate pathway. We investigated that in porcine POP, b-
propeller pore size increases in diameter by ,2A ˚ indicating
smaller product release can be from this route as free energy
barrier was reduced. But this increase in b-propeller pore size in
bound form was not observed in human and A. thaliana. Similarly,
analysis of strong hydrogen bond interactions suggests intactness of
human POP during both bound and unbound form of simulations.
These differences showed difference in free energies for opening
motion of two domains in different species. However, we also
suspect that these differences in strong hydrogen bonds and b-
propeller pore size variation could lead to differences in routes of
substrate entry and product release. We found that lysines present
on blade one and seven continuously hide the b-propeller pore
opening. This effect was more prevalent in human bound form
than porcine which leads to broader opening of b-propeller in
porcine. It is yet to be figure out that the opening of b-propeller
pore is a pH dependent mechanism or not? It is possible that
because of the change in pH lysines present on blade one and
seven will allow broadening of the annulus of the tunnel and
thereby movement of small molecules. In porcine this broad
opening of pore acts as a passage for the smaller product
movement. But we suspect whether this opening could allow larger
product movement? Answering this requires still longer length
simulations of both bound and unbound form of proteins. This
study also showed that in POPs mode of substrate entry/product
egress are via different paths as reported in other POP family
members.
Sequence analysis showed that in some species like nema-
todes, arthropods and even in plants, lysines covering b-
propeller pore are absent which would increase diameter of b-
propeller pore and eventually can even allow bigger product
movement. To our knowledge, this is the first study that reflects
role of b-propeller in product movement. As human POP was
found to be incapable of binding to few ligands like UAMC and
Y-29794, molecular docking with 20
th ns structure of human
unbound form was re-performed. This showed that after
subjecting protein to dynamic state, ligand binding is possible
as both the above ligands which showed hindrance in binding
were found to bind well due to change in the orientation of the
binding as shown in Figure S9 (rigid docking score of
UAMC:25.94 kcal/mol, Y-29794: 24.26 kcal/mol). This de-
picts that conformational changes are necessary especially at the
active site of protein.
This analysis showed differences in conformational dynamics of
three POP species with respect to ligand binding and product
release. On the whole, the current analysis confirms that the ligand
affinities and mode of product egress are different for the plant,
porcine and human POPs suggesting that studies with potential
drugs have to be carefully interpreted. This work is likely to have
implications for the design of inhibitors acting at POP and could
contribute to development and maturation of novel leads for
neurodegenerative diseases. This analysis will enhance our
understanding of evolutionary history of POP protein and will
also contribute to understanding of function of the enzyme.
Supporting Information
Figure S1 Electrostatic surface potential of b-propeller
domain of three species. a) Porcine b) Human c) A. thaliana
POPs. The surface between blades 1 and 7 is shown by a black arc
for clarity. The blade one of b-propeller is more positively charged
in porcine and human as compared to A. thaliana. Presence of an
extra Arg402 on mouth of b-propeller pore of A. thaliana makes it
more positive.
(TIF)
Figure S2 Blind docking results of three POPs using Z-
pro prolinal as an inhibitor. a) porcine b) human c) A. thaliana
POP. Inhibitor shown in red color was sampled 100 times.
(TIF)
Figure S3 Blind docking of a dummy molecule. Blind
docking was done to porcine POP to validate whether binding of
substrate is random or not. Sucrose was found to have affinity all
over the protein while substrate (angiotensin) binding was limited
to some expected places. Figures below show comparison of
binding poses of sucrose and angiotensin.
(TIF)
Figure S4 Percentage docked poses of substrate and
product. Docked poses were compared between porcine and
human POP a) In porcine POP, out of hundred sampling substrate
was not found to bind at inter-domain cavity and also newly
reported cavity while product was found to bind all over except
inter-domain cavity b) In human POP, substrate has tendency to
bind in similar way to porcine POP while product has affinity to
bind all over protein.
(TIF)
Figure S5 Backbone (C
a) RMSD of two domains. RMSD
of b-propeller (black) and a/b-hydrolase (red) domains separately
in porcine POP. RMSD of entire protein (green) is also
represented. b-propeller showed higher fluctuations then a/b-
hydrolase.
(TIF)
Figure S6 RMSD of drug present in binding pocket
during bound form simulation of porcine and human
POP. a) drug in porcine POP binding pocket b) drug in human
POP binding pocket.
(TIF)
Figure S7 Figure shows b-propeller pore size variations
during molecular dynamics replicate runs. Overall,
porcine POP shows increase in b-propeller pore size while human,
A. thaliana POP these changes were not very high. A. thaliana POP
shows slight decrease in pore size.
(TIF)
Figure 11. Free energy profile of smaller product movement through b-propeller in porcine POP. a) 0
th ns structure which showed huge
barrier around b-propeller pore. b) 20
th ns structure where free energy barrier was reduced.
doi:10.1371/journal.pone.0026251.g011
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PLoS ONE | www.plosone.org 15 November 2011 | Volume 6 | Issue 11 | e26251Figure S8 Superimposed structures of porcine, human
and A. thaliana POPs before (0 ns) and after MD (20 ns).
Protein shown in green color is 0 ns structure while in blue color is
20 ns structure. Drug (ZPR) is shown in tint (0 ns) and magenta
color (20 ns). Figure shows the difference in orientation of drug
after 20 ns in all three species.
(TIF)
Figure S9 Docking results showing mode of binding of
ligands in 0 ns (green) and 20 ns (blue) structures of
human POP. a) UAMC bound to human POP, 0 ns complex is
shown green(receptor) and tint (UAMC) color, short contact with
Ile-478 is shown in yellow circle b)Y-29794 bound to human POP
(b.i) 0 ns structure. (b.ii) 20 ns structure. Residues present in
vicinity (4 A ˚) are shown in yellow color.
(TIF)
Figure S10 Secondary structure alignment of porcine
POP (1E5T) used as a template for building the model
structure of A. thaliana. It clearly shows the agreement of
secondary structure elements between two protein sequences.
Yellow and pink color indicates beta-strands and alpha helices
respectively.
(TIF)
Table S1 Distance between two domains. This distance
was calculated using Pro34 and Thr200. Distances of replicate
runs are shown in brackets.
(DOC)
Table S2 Distance between blades one and seven during
simulation (Cys78 and Glutamine 397). Distances of
replicate runs are shown in brackets.
(DOC)
Table S3 Residues involved in strong hydrogen bond
formation. a) Number of strong hydrogen bonds during
simulations of bound and unbound forms of porcine, human, A.
thaliana b) Strong inter-domain hydrogen bonds in porcine,
human, A. thaliana POPs in unbound form. Comparison was done
between 0 ns and 20 ns structures c) Strong inter-domain
hydrogen bonds in bound form of POP species. Residues in bold
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